www.advancedsciencenews.com www.advhealthmat.de formation of phagophore, followed by the insertion of LC3 protein into the phagophore membrane to engulf intracellular cargos. Consequently, a double-membrane structure, autophagosome, is formed. The autophagosomes and lysosomes are then fused together to form autolysosomes. In the autolysosomes, the engulfed intracellular cargos will be biodegraded and recycled. Autophagy may promote cell survival and suppress apoptosis. It may also contribute to cell death, either together with apoptosis or replacing defective apoptosis. Rapid release of zinc ions in a solution, especially in an acidic pH, is a characteristic of ZnO NPs. [13] Although zinc is a necessary trace element in the body, [14] excessive accumulation of the local concentration of zinc ions will lead to cellular zinc homeostasis and cause lysosome and mitochondria damage. [15] However, whether zinc ions released from NPs or NPs themselves are responsible for the cell death remains to be ambiguous.
Cancer cells present a relatively high metabolic activity and a disordered mitochondrial function compared to normal cells, and thus they bear an improved level of reactive oxygen species (ROS) in comparison to normal cells. Hence, the cancer cells are more vulnerable to ROS accumulation. [16] Excessive ROS can induce apoptosis and autophagy. [17] The classical AKT/mTOR pathway is also reported to be involved in autophagy. [17] However, it is still unknown whether the AKT/mTOR pathway was activated and ROS were produced in ZnO NP-treated osteosarcoma cells.
Here, we demonstrated that ZnO NPs could suppress osteosarcoma cell proliferation by causing S phase arrest and induce cell death due to an induction of both apoptosis and autophagy. We also studied the upstream Akt/mTOR signaling pathways and the possible regulatory mechanisms of the cross talk between apoptosis and autophagy. We further clarified that ZnO NP-induced osteosarcoma cell death resulted from a high concentration of intercellular zinc ions but not from NPs. Simultaneously, it was verified that ZnO NPs could utilize autophagy to enhance zinc ion release from the uptaken ZnO NPs. The released zinc ions, combined with the inflow of zinc ions (derived from the extracellular zinc ions release from ZnO NPs), target and damage the mitochondria, which could contribute to excessive ROS generation to promote apoptosis, ultimately triggering osteosarcoma cell death. These findings suggest an important biomedical application of ZnO NPs and provide a novel sight for targeting osteosarcoma.
Results

Characterization and Cellular Uptake of ZnO NPs
Our transmission electron microscopy (TEM) observed that the ZnO NPs had a size of ≈50 nm and were roughly spherical (Figure 1c) , which was in accord with the description of this nanoparticle purchased from Sigma (677450). To verify the cellular uptake of NPs, we used TEM to observe the cells treated with ZnO NPs, and confirmed that the NPs were internalized mainly via large intracellular cytoplasmic vacuoles (Figure 1b,c) .
ZnO NPs Exhibited a Preferential Effect on the Osteosarcoma Cell Proliferation
The four human osteosarcoma cell lines (U-2OS, MG-63, Saos-2, and143B) and two types of normal cell lines (HUVEC and hFOB1. 19) were separately allowed to interact with ZnO NPs of various concentrations for different times (Figure 2a) . After 24 h, the ZnO NPs have a different IC 50 value for different cancer cell lines, specifically, 13.84 µg mL −1 for 143B, 32.43 µg mL −1 for U-2OS, 18.13 µg mL −1 for Saos-2 cells, and 23.4 µg mL −1 for MG-63. The IC 50 for treatment with ZnO NPs for 48 h was 12.48 µg mL −1 for 143B, 28.49 µg mL −1 for U-2OS, 14.69 µg mL −1 for Saos-2 cells, and 21.49 µg mL −1 for MG-63. Treatment with ZnO NPs showed fewer colonies in both U-2OS and Saos-2 cells than those in control groups (Figure 2b ). Moreover, HUVEC and hFOB1.19 cells showed obvious stronger resistance to ZnO NPs than that of the four osteosarcoma cell lines (Figure 2d ). These results indicated that ZnO NPs inhibited the proliferation of human osteosarcoma cells in a dose-and time-dependent manner and demonstrated less cytotoxic effect against normal cells, which were in line with previous studies. [6b,13] 
ZnO NP-Induced S Phase Arrest
Previous studies have verified that ZnO NPs could induce cell cycle arrest to inhibit cell proliferation. [18] To verify that ZnO NPs suppressed the proliferation of osteosarcoma cells through triggering cell cycle arrest, we evaluated the change in the cell cycle distribution after the cancer cells were subjected to ZnO NPs treatment. Figure 2c showed NPs caused S phase accumulation and correspondingly G0/ G1 phase in both U-2OS and Saos-2 cells was decreased. To understand the reason behind this observation, we quantified the expressions of Cdc25C, Cyclin A2, CDK1, and CDK2. We found that these four proteins, for driving the S to G2/M phase transition in a cell cycle, were obviously decreased in response to the ZnO NP treatments (Figure 2e ). Hence, S phase was arrested after ZnO NPs treatment by altering S phase-regulating proteins.
ZnO NP-Induced Cell Apoptosis
To verify whether apoptosis contributed to the osteosarcoma cell proliferation inhibition by ZnO NPs, we performed 4′,6-diamidino-2-phenylindole (DAPI) staining, flow cytometry, TEM imaging, and Western blotting assays. Figure 3a showed that DNA fragmentation and chromatin condensation occurred after the cancer cells were exposed to ZnO NPs. To determine the apoptotic proportion, annexin V-FITC/PI was Colony formation assay of U-2OS and Saos-2 cells exposed to ZnO NPs. c) Flow cytometry analysis of the cell cycle after the cells were exposed to ZnO NPs for 24 h. d) Comparison of the inhibitory effect on four osteosarcoma cell lines and two normal cell lines by ZnO NPs (50 µg mL −1 ) for 24 h. e) Western blot analysis of the cell-cycle-regulated proteins expressions in the U-2OS cells after they were treated with ZnO NPs of varying concentrations for 24 h or with ZnO NPs (50 µg mL −1 ) for different times. Statistically significant differences were evaluated using the paired Dunnett's t-test or one-way ANOVA. Results were expressed as the mean ± S.D. from three independent experiments. *P < 0.05 versus control, #P < 0.05 versus ZnO NPs treatment.
www.advancedsciencenews.com www.advhealthmat.de employed to stain the NP-treated osteosarcoma cells. Both early and late apoptotic proportion were increased in response to treatment with ZnO NPs for 24 h when compared to the control group (Figure 3b ). JC-1 fluorescent probe was also used to label the mitochondrial membrane. Fluorescent microscopy showed an obvious shift from red to green in the mitochondrial membrane after ZnO NPs treatment ( Figure S1b , Supporting Information), indicating a decrease of the mitochondrial membrane potential (MMP) following ZnO NPs treatment as quantified by flow cytometry (Figure 3c ). Moreover, Western blotting detected an upregulation of Bax/Bcl2 ratio and a translocation of Cytochrome c (cyt c) from the cytoplasm to mitochondria after ZnO NPs treatment (Figure 3d-f) . Then, we investigated the expression of major related proteins in the extrinsic and intrinsic apoptosis pathways. As shown in Figure 3d ,e, ZnO NPs markedly changed the level of one marker for the intrinsic pathway (caspase-9), two markers for the extrinsic pathway (Fas and caspase-8), and one marker for both intrinsic and extrinsic pathway (caspase-3). Furthermore, we also conducted a protein activity assay to detect the caspase-3 activity.
The result exhibited that the activity of the enzyme (caspase-3) was enhanced with the increase of the amount of ZnO NPs for treating the cancer cells (Figure 3g ). To further verify that apoptosis contributed to the ZnO NPinduced death of the osteosarcoma cells, we studied the U-2OS cell viability when they were first pretreated using z-vad-fmk (an apoptosis inhibitor, i.e., a well-known pan caspase inhibitor) and then exposed to ZnO NPs. Unexpectedly, the cell viability was only partially restored with no more than 10% (Figure 3h ) although apoptosis was successfully inhibited (Figure 3i ), suggesting that other pathways may be involved in ZnO NP-induced osteosarcoma cell death.
ZnO NP-Triggered Autophagy by Enhancing Autophagosomes Formation and Impaired Lysosomal Function
It was recently known that autophagy could also contribute to cell death. [10a,11f,g] We observed that ZnO NPs enhanced the immunofluorescence intensity of LC3 (Figure 4a ). Our TEM results showed that numerous vacuoles in the cytoplasm (a sign of autophagy), along with chromatin condensation (a sign of apoptosis), were found after the osteosarcoma cells were treated with Enhanced accumulation of autophagosomes could arise from either enhancement of autophagosomes formation or blockade of autolysosomes formation. In order to understand which is the case for ZnO NP-induced autophagosome accumulation, we quantified the LC3-I to LC3-II transition with or without the addition of chloroquine (CQ), an inhibitor for increasing the pH of the lysosomes and blocking the capability for the autophagosomes to fuse with lysosomes. In the presence of the CQ, the level of LC3-II only depended on the formation of autophagosomes and thus served as a marker for the autophagy induction. Using the Western blot assay, we found that treatment with ZnO NPs led to an elevation in the LC3-II/ LC3-I ratio regardless of the presence of CQ (Figure 3e ). These results suggested that ZnO NPs indeed led to autophagosomes formation but still could not preclude a possibility that the formation of autolysosomes was blocked due to the lysosomal function disruption. To understand this, the autophagic degradation was monitored by measuring the expression of SQSTM1/p62, which is a protein substrate that can be specifically integrated into the autophagosomes and biodegraded in the autolysosomes). Its expression was increased in the NP-treated cells, and further increased when CQ was present ( Figure 4f ). Taken together, we could conclude that ZnO NPs not only induced the formation of autophagy by enhancing autophagosomes but also impaired lysosomal function in human osteosarcoma cells.
Involvement of Akt/mTOR Pathway in ZnO NP-Triggered Human Osteosarcoma Cell Death
Inhibiting Akt/mTOR pathway is recognized as a common and important regulatory mechanism of autophagy. [19] Figure 4a confirmed that decrease in the levels of both p-Akt and p-mTOR was significant when the cells were treated with ZnO NPs and p-S6 (a substrate for mTOR). However, rapamycin (an inhibitor of m-TOR) failed to enhance cell death (Figure 5b) . These results suggested that although Akt/mTOR signaling pathway was activated, it was not the rate-limiting upstream pathway during the ZnO NP-induced osteosarcoma cell death.
The Role of Zinc Ions in NP-Triggered Human Osteosarcoma Cell Death
Elevation of Intracellular Zinc Ions Sequestrated by the Mitochondrion Contributed to Osteosarcoma Cell Death
Since zinc ions can become toxic to the cells, [13,15b] we further examined the concentration of intracellular zinc ions after ZnO NPs treatment by inductively coupled plasma-mass spectrometry (ICP-MS). The results revealed that zinc ions concentration was markedly elevated in both U-2OS and Saos-2 cells (Figure 6a) . Interestingly, Saos-2 cells contained a higher level of zinc ions than U-2OS, which may be the reason why Saos-2 cells were more susceptible to ZnO NPs ( Figure 2a ). Considering the relationship between mitochondrion and apoptosis, we then, respectively, detected the level of zinc ions in the mitochondrion and cytoplasm. Figure S3a (Supporting Information) showed that the level of zinc ions obviously increased both in mitochondrion and cytoplasm while the level in mitochondrion was much higher than that in cytoplasm, indicating that increased intracellular zinc ions might be sequestrated by mitochondrion. To verify whether the increasing concentration of zinc ions enhanced the cell death, ethylenediaminetetraacetic acid (EDTA), which could chelate zinc ions, was added 1 h before ZnO NPs treatment to chelate zinc ions in solution. The cell ability assay showed that pretreatment with EDTA could completely abolish ZnO NP-induced cell death regardless of its effect on cell viability (Figure 6b ). ICP-MS also confirmed that intracellular zinc ions concentration nearly decreased to a normal level (Figure 6h ), indicating that ZnO NP-induced cell death was due to the elevation of the level of intracellular zinc ions. To further verify this hypothesis, we evaluated the effect of the ZnCl 2 solution. The result showed that ZnCl 2 solution could also induce cell death in a way similar to ZnO NPs and successfully induce autophagy and apoptosis, as evidenced by upregulating the expression of related proteins (Figure 6c,d) . To further investigate whether the high concentration of intracellular zinc ions was the sole mediator contributing to the cell death, we compared the concentration of intercellular zinc ions under the equivalent inhibitory effect of ZnCl 2 and ZnO NPs solution. The data exhibited that the level of zinc ions in ZnO NPs group was even higher than the ZnCl 2 group (Figure 6e) , suggesting that the intracellular zinc ion concentration treated with ZnO NPs possessed the ability to kill the human osteosarcoma cells alone. In addition, our www.advancedsciencenews.com www.advhealthmat.de TEM directly showed that the cell ultrastructure was nearly intact after pretreatment with EDTA regardless of uptaken ZnO NPs (Figure 5b ), indicating that it was the intracellular zinc ions but not NPs that contributed to the cell death. Collectively, these results confirmed that high concentration of intracellular zinc ions was the source of inducing human osteosarcoma cell death.
Intracellular Zinc Ions Inflowed from Extracellular Source and Released from Uptaken NPs Synergistically Led to NP-Induced Human Osteosarcoma Cell Death
After we had proved that zinc ions triggered the osteosarcoma cell death, efforts were made to clarify whether the cell death resulted from the inflowed zinc ions uptaken from the extracellular environment or those released from the uptaken ZnO NPs, or a combination of both. Thus, CaCl 2 solution, a common agent to block zinc ions uptake, [20] was used to evaluate whether zinc ions uptake was required for ZnO NPinduced cell death. Our data showed that CaCl 2 treatment could completely abolish ZnO NP-induced cell death (Figure 6f) . Additionally, the ICP-MS confirmed that the level of zinc ions in the supernatant was increased while the amount of intracellular zinc ions was correspondingly reduced (Figure 6g,h ). These data suggested that CaCl 2 successfully impeded the entry of toxic zinc ions into the cells and then prevented cell death. Unexpectedly, Western blot results from the cells pretreated with CaCl 2 showed a considerably higher LC3-II/LC3-I ratio than the EDTA and control groups, but all of those groups did not detect the cleavage of pro-caspase3 (Figure 6i) , indicating that the level of intracellular zinc ions with the addition of CaCl 2 was not high enough to cause cell death but have the ability to induce autophagy. Our TEM results clearly exhibited cell ultrastructure without obvious damage but with obvious accumulation of autophagic vacuoles ( Figure S2b , Supporting Information), which were in accordance with the result of Western blotting. These data suggested that the zinc ions, which were released from the extracellular ZnO NPs and then flowed into the cells, as well as intracellular zinc ions, which were released from the uptaken ZnO NPs, were both important for ZnO NP-induced cell death. To test this hypothesis, we quantified the concentration of zinc ions in Dulbecco's modified Eagle medium (DMEM) after the ZnO NPs were placed in the medium. A standard filter assay revealed that the released zinc ion concentration in DMEM was elevated from 0.34 to 24.4 µg mL −1 after the NPs were incubated in the medium for 1 d at the body temperature (Figure 6g) . Zinc ions at these concentrations were not toxic to the osteosarcoma cells according to the inhibitory curve of ZnCl 2 (Figure 6c) . Even when the concentration of ZnCl 2 reached 50 µg mL −1 , approximately twice that of released zinc ions from ZnO NPs, the zinc ions still did not show high cell viability inhibition (Figure 6c ). These data suggested that the inflow of extracellularly released zinc ions was an indispensable but not the sole determining factor in ZnO NP-induced cell death. Taken together, we could come to a conclusion that the inflow of the extracellularly released zinc ions (from extracellular ZnO NPs) and production of intracellular released zinc ions (from uptaken ZnO NPs) synergistically led to human osteosarcoma cell death.
Cross Talk between Apoptosis and Autophagy in ZnO NP-Induced Human Osteosarcoma Cell Death
Apoptosis can be interrelated to autophagy. [21] However, the cross talk between them in ZnO NP-induced death of cancer cells has never been explored. To fill this gap, first, we examined for different times. e,f) Western blotting analysis of LC3 and p62 levels in U-2OS cells after they were incubated with or without ZnO NPs (50 µg mL −1 ) for 24 h after 2 h pretreatment with CQ (10 × 10 −6 m). LC3 and p62 levels were detected by Western blotting and quantified by densitometric analysis relative to β-actin. Statistically significant differences were evaluated using the paired Dunnett's t-test or one-way ANOVA. Results were expressed as the mean ± S.D. from three independent experiments. *P < 0.05 versus control, # P < 0.05 versus ZnO NPs treatment. Figure 5 . Effect of ZnO NPs on the Akt/mTOR signaling pathway. a) Western blotting analysis of the expression of mTOR/p-mTOR, Akt/p-Akt, and S6/p-S6 in the U-2OS cells after they were treated with ZnO NPs for 24 h. b) CCK-8 analysis of U-2OS cells after they were pretreated with rapamycin for 2 h and exposed to ZnO NPs (40 µg mL −1 ) for 24 h. Statistically significant differences were evaluated using the paired Dunnett's t-test or one-way ANOVA. Results were expressed as the mean ± S.D. from three independent experiments. *P < 0.05 versus control.
www.advancedsciencenews.com www.advhealthmat.de the effect of apoptosis suppression on the autophagy. Figure 7a showed that z-vad-fmk significantly enhanced the level of AO-staining. Correspondingly, Western blotting revealed that the LC3-II/ LC3-I ratio was further increased in the presence of the apoptosis inhibitor in comparison to the control group without cleavage of pro caspase-3 (Figure 7b ), suggesting that the mechanism of cell death was changed from apoptosis to autophagy when the inhibitor was used to inhibit apoptosis. These results indicated that inhibiting apoptosis would enhance autophagy. Next, we examined the apoptosis when the autophagy was suppressed by an inhibitor. Autophagy included the phase of forming autophagosomes (at the early stage of autophagy) and another phase of forming autolysosomes (at the late stage of autophagy). [21] Here, we respectively blocked these two phases to observe the influence on ZnO NP-triggered human osteosarcoma cell death. We found that 3-methyladenine (3-MA), an inhibitor for inhibiting the autophagosomes formation, prevented the ZnO NP-induced cell death regardless of the influence of the inhibitor itself (Figure 7c ). The flow cytometry revealed that 3-MA sharply decreased the proportion of AO-staining approximately to a normal level (Figure 6d ), and completely avoided the NP-induced apoptosis ( Figure 7d ) and MMP reduction ( Figure S3a , Supporting Information). This was further evidenced by inhibiting the LC3-II/ LC3-I ratio and diminishing the procaspase-3 cleavage (Figure 7e ). Moreover, 3-MA also reduced the concentration of intracellular zinc ions (Figure 7i ). These results revealed that autophagosomes induction was positively related to the elevating concentration of intracellular zinc ions and ZnO NP-induced cell death. Then, we blocked the late stage of autophagy (autolysosomes formation) with CQ, the result unexpectedly showed that CQ not only failed to rescue the fate of cell death but inversely promote the apoptosis without a significant fluctuation of intracellular zinc ion concentration (Figure 7f-h h) The concentration of intracellular zinc ions detected by ICP-MS in the presence and absence of EDTA or CaCl 2 . i) LC3 and pro caspase-3 levels were detected by Western blotting in the presence and absence of EDTA or CaCl 2 . Statistically significant differences were evaluated using the paired Dunnett's t-test or one-way ANOVA. Results were expressed as the mean ± S.D. from three independent experiments. *P < 0.05 versus control, # P < 0.05 versus ZnO NPs treatment.
www.advancedsciencenews.com www.advhealthmat.de with z-vad-fmk. As we expected, the result showed a considerable increase of the cell viability (Figure 7j ), indicating that there indeed existed a conversion between autophagy and apoptosis. Collectively, we could conclude that inhibiting the autophagosomes formation could downregulate the level of intracellular zinc ions and then abolish ZnO NP-induced osteosarcoma cell death while suppression of either the formation of autolysosomes or apoptosis would push one to the other.
ZnO NP-Induced ROS Generation Contributed to ZnO NP-Induced Human Osteosarcoma Cell Death
ROS Generation Triggered Apoptosis and S Phase Arrest
ROS could regulate cell cycle arrest and apoptosis. [22] Figure 8a showed that ROS level was higher in both low and high concentrations at 24 h than the control groups. Interestingly, the high concentration group contained a relatively lower level of ROS production compared to the low concentration group, probably because the high concentration would lead to severe cell damage, resulting in the leak of ROS production. We further used an ROS scavenger (N-acetyl-l-cysteine (NAC)) to verify that ROS were involved in ZnO NP-triggered cell death. We found that NAC inhibited the ROS production triggered by ZnO NPs ( Figure S3b , Statistically significant differences were evaluated using the paired Dunnett's t-test or one-way ANOVA. Results were expressed as the mean ± S.D. from three independent experiments. *P < 0.05 versus control, # P < 0.05 versus ZnO NPs treatment. Supporting Information), avoiding NP-induced apoptosis (Figure 8b ,c) and MMP reduction ( Figure S3c , Supporting Information). In addition, NAC also inhibited ZnO NP-induced S phase arrest and the change in the regulator markers of the S cell cycle (Figure 8d ,e). All these data revealed that ROS was the upstream of apoptosis and S phase arrest in ZnO NP-induced osteosarcoma cell death.
Copromotion between Autophagy and ROS
ROS induced by different kinds of NPs have been reported to be the upstream of autophagy. [23] Thus, we considered whether ZnO NP-induced ROS were the autophagy inducer. To determine the influence of ROS generation on the ZnO-NP-induced autophagy, we quantified the AO-staining intensity and LC3-II/LC3-I ratio with and without the addition of NAC. Figure 8f ,h showed that NAC clearly decreased the LC3-II/LC3-I ratio when ZnO NPs were present and obviously weakened the AO-staining intensity. In contrast, Figure 8g revealed that 3-MA could also reduce the ROS level. These results suggested that there might exist a copromotion relationship between the autophagy and ROS.
Discussion
Recently, it has been demonstrated that ZnO NPs contain an antitumor potential with a higher cancer cell selectivity compared to the traditional chemotherapeutic agents. [13] However, the mechanism at the subcellular level has never been deeply studied before. [6a,10a,11g] Moreover, no study has been made about the ZnO NP-induced f) The levels of AO staining in the presence and absence of NAC analyzed by flow cytometry. g) LC3 levels detected by Western blotting and quantified by densitometric analysis relative to β-actin. h) The levels of ROS analyzed by flow cytometry after the cells were labeled with DCFH-DA for 30 min. Statistically significant differences were evaluated using the paired Dunnett's t-test or one-way ANOVA. Results were expressed as the mean ± S.D. from three independent experiments. *P < 0.05 versus control, # P < 0.05 versus ZnO NPs treatment. osteosarcoma cell death. In this work, by systematically studying the role of autophagy and apoptosis as well as their cross talk in inducing the death of ZnO NP-treated cells, and the role of zinc ions in the apoptosis and autophagy, we have made a step further to the understanding of the subcellular mechanism by which ZnO NPs triggered cancer cell death. We discovered that the apoptosis of osteosarcoma cells was triggered by ZnO NPs through activating the extrinsic and intrinsic pathways (Figure 3d-f) . However, the caspase inhibitor z-vad-fmk only partially prevented the cell death, suggesting that there might exist other caspase-independent pathways in ZnO NP-induced human osteosarcoma cell death (Figure 3h,i) . In our study, autophagy was induced and confirmed by the formation of autophagosomes, enrichment of acidic vesicles (AO-staining), enhancement of LC3 immunofluorescence, and upregulation of LC3-II/ LC3-I ratio (Figure 4a-d) . It was further confirmed by the elevation of the LC3-II/ LC3-I ratio when the autolysosomes formation was blocked (Figure 4e) . Moreover, we found that ZnO NPs treatment elevated the level of p62 expression, suggesting that autophagic flux was impaired by ZnO NPs treatment (Figure 4f ). Autophagy can be negatively regulated by Akt/ mTOR signaling through mediating the phosphorylation of mTOR. [17] Our current results showed that ZnO NPs triggered inhibition of p-Akt, p-mTOR, and p-S6 (Figure 5a ). However, suppression of m-TOR with rapamycin failed to promote osteosarcoma cell death (Figure 5b ), suggesting that Akt/m-TOR signaling pathway might be involved in but not the determining upstream pathway for autophagy. Further work is needed to clarify which upstream pathway is the dominant factor in triggering autophagy.
Our data also confirmed an obvious increase in the level of intracellular zinc ions in cytosol and mitochondria. We further observed a tendency that the concentration of zinc ions in mitochondria was much higher than that in cytosol, indicating that zinc ions uptake into cytosol would be eventually sequestrated by mitochondria ( Figure S2a, Supporting Information) . Furthermore, we confirmed that it was the zinc ions but not the NPs that actually contributed to the human osteosarcoma cell death by comparing the concentration of intracellular zinc ions after ZnO NPs and ZnCl 2 solution treatment under the condition of the equivalent killing effect. We further verified that the cell death was completely abolished by zinc-specific chelating agents such as EDTA (Figure 6b ). We also provided that both the inflow of extracellularly released zinc ions (from extracellular ZnO NPs) and the intracellular released zinc ions (from uptaken ZnO NPs) were indispensable for ZnO NP-induced human osteosarcoma cell death. From the above experimental results, we proposed a new mechanism of ZnO NP-induced osteosarcoma cell death. Namely, our work showed that ZnO NP-induced osteosarcoma cell death through the cross talk between two mechanisms of programmed cell deaths, the autophagy and apoptosis (Figure 9) . Specifically, the uptake of ZnO NPs induced the accumulation of autophagosomes and impaired the lysosomal functions, promoting the early and late stage of autophagy, respectively. The autophagy further triggered the zinc ions release from the uptaken ZnO NPs. The resultant zinc ions, together with the inflowed zinc ions (released from the extracellular ZnO NPs), collectively targeted and damaged the mitochondria, resulting in the generation of ROS. The ROS then inhibited the cell proliferation by S phase arrest and induced cell apoptosis through the extrinsic and intrinsic pathways, ultimately leading to cell death. This cross talk mechanism has been further supported by three important results. First, the elimination of ROS with NAC completely reversed the cell viability (Figure 8b ). Second, inhibiting the early stage of autophagy with 3-MA abolished the apoptosis while inhibiting the late stage of autophagy with CQ inversely promoting the apoptosis (Figure 7e,g ). Third, suppressing apoptosis with z-vad-fmk failed to rescue cell death but enhanced autophagy (Figure 7a,b) .
Conclusion
In conclusion, our study provided potential mechanistic pathways for ZnO NP-induced human osteosarcoma cell death. We discovered that ZnO NPs could suppress the proliferation of human osteosarcoma cells through the induction of S phase arrest and trigger the cell death through mediating autophagy and apoptosis in a ROS-dependent manner. We also clarified that apoptosis inhibition would contribute to autophagy whereas suppressing the early or late stage of autophagy resulted in an inverse effect on the cell death. In addition, we determined that it was the intracellular zinc ions but not the NPs themselves that initiated the process of the cell death, and ZnO NPs could induce autophagy to regulate zinc ions releasing. Collectively, the ZnO NP-induced cross talk between the autophagy and apoptosis determined the cell fate. These compelling results expanded our understanding of clinical applications of ZnO NPs for targeted osteosarcoma therapy.
Experimental Section
Reagents, Antibodies, Nanoparticles, and Cells: All chemicals, including AO, CQ, EDTA, z-vad-fmk, NAC, JC-1 dye, CaCl 2 , 3-MA, and rapamycin, were purchased and directly used without any further purification. Ultrapure water (Milli-Q Biocel) was used as universal solvent unless otherwise indicated. Antibodies against Bax, Bcl-2, Fas, LC3, SQSTM1/p62, AKT, m-TOR, S6, CDK1, CDK2, CDC25C, Cyclin A2, caspase-9, caspase-8, caspase-3, cytochrome c, β-actin, and GAPDH were also used as received. ZnO NPs were obtained from Sigma-Aldrich (677450). Their shape and size were confirmed by TEM. All cells used were purchased from ATCC, including four human osteosarcoma cell lines (U-2OS, MG-63, Saos-2, 143B).
Exposure of Cells to Nanoparticles: ZnO NPs were placed in ultrapure water to form a suspension of 1 mg mL −1 and immediately dispersed under sonication (200 W for 30 min) to make the suspension fully dispersed. Then the suspensions were added into the complete medium to give final concentrations, which range from low to high dose (5, 10, 20, 30, 40, 50 µg mL −1 ). Finally, the NPs were placed into the cell culture medium at varying concentrations.
Cell Viability Assay: CCK-8 kit, from Dojindo Laboratories (Kumamoto, Japan), was utilized to characterize the inhibition of cell proliferation by ZnO NPs following a reported protocol. [24] Cell culture medium without NPs or with NPs alone (No cells) was also characterized as controls. In the rescue experiments, the cells were first treated with EDTA, CaCl 2 , NAC, 3-MA, z-vad-fmk, and CQ for about 1 h.
Colony Formation Assay: Cells with a seeding density of 100 cells/ well were cultured. After overnight, they were cocultured with ZnO NPs at varying concentrations for about 10 d till colonies were visible. 4% paraformaldehyde was used to fix the colonies and then 0.1% crystal violet was used to stain them for 10 min. Finally, the visible colonies were counted.
DAPI Staining: The changes of apoptotic characteristic were assessed by DAPI staining. After staining, a fluorescence microscope was used to visualize the chromatin condensation as well as nuclei fragmentation.
TEM Imaging: NP-induced change in the cell ultrastructure was observed by TEM. Apoptosis and autophagy were determined by observing cell nuclear condensation and autophagosomes formation. Briefly, the cells were purified by centrifugation (800 g) after tyrosination and then successively fixed first by 2.5% glutaraldehyde and by 1% osmium tetroxide, and then treated with alcohol for dehydration. Finally, the cell pellets were placed into epoxy by embedding. Ultrathin sections were obtained using a microtome and observed under TEM.
FACS Analysis: Cells with a seeding density of 2 × 10 5 cells per well were interacted with ZnO NPs of varying concentrations for 1 d. To determine NP-triggered change in cell cycle, the cells were purified by centrifugation after treatment treated with ZnO NPs, then treated with 70% ethanol in a freezer (−20 °C). They were then incubated with PI/ RNase staining buffer at 37 °C for half an hour. To detect apoptosis, the cells were labeled using annexin V-FITC/Propidium Iodide Apoptosis Detection Kit for 15 min under no light condition. Then the cells were purified and then resuspended in PBS. An ROS Assay kit with DCFH-DA was utilized to verify ROS production. A JC-1 fluorescent probe was used to quantifying the MMP changes. For detecting the function of lysosomes, an AO dye was diluted in complete medium to 1 × 10 −6 m, then incubated with cells at 37 °C for half an hour. The cells stained as above were then quantified by a flow cytometer.
Caspase-3 Activity Assay: A Caspase Activity Kit was purchased from Beyontime Biotechnologies in China and used to quantify the activity of the enzyme Caspase-3. After the NPs were interacted with the cells for 1 d, the cell lysates were prepared, and the enzymatic activity was measured following the manufacturer's protocol and reflected as the absorbance of the enzyme substrate at 405 nm.
Zinc Ion Release Assay: ZnO NPs suspension (1 mg mL −1 , diluted with ultrapure water) was added into DMEM complete culture medium to reach a mixture concentration (50 µg mL −1 ). The cells were then incubated for 1 d and ultracentrifuged (15 000 g for 30 min) to detach the NPs. Then, HNO 3 and H 2 O 2 were used to dissolve the resulting supernatant. Finally, the concentration of zinc ions in the resultant solution was determined using ICP-MS. To detect the total intercellular zinc ion concentrations, the cells were allowed to interact with 50 µg mL −1 NPs with or without being pretreated with EDTA, CaCl 2 , 3-MA, CQ, or ZnCl 2 (100 µg mL −1 ) for 1 d. Then the cells were washed and collected, then divided into two groups. One group was used to measure protein content, and the other was used to quantify the zinc ions by ICP-MS. To separately quantify the concentration of zinc ions in cytoplasm and mitochondria after ZnO NP-treated cells. Fractions of cytoplasm and mitochondria were separated by Cell Mitochondria Isolation Kit (Beyotime Biotechnology, Jiangsu, China) and then divided into two tubes followed as above.
Immunofluorescence Microscopy: After the cells with an original seeding density of 5 × 10 5 /well were interacted with ZnO NPs for 24 h, they were then fixed with 4% paraformaldehyde followed by 1 h treatment with 5% bovine serum albumin (BSA) to achieve blocking. Thereafter, the cells www.advancedsciencenews.com www.advhealthmat.de were stained first with an anti-LC3 antibody for 1 h and then with a Cy3 488-conjugated AffiniPure goat anti-rabbit IgG for 1 h, followed by DAPI staining and fluorescence microscopy imaging. Western Blot Analysis: The cells were first interacted with ZnO NPs for 1 d. Then they were collected and lysed using RIPA lysis buffer added with protease and phosphatase inhibitors. Ultracentrifugation was carried out to purify the lysates and the resultant supernatant was treated using a mitochondria isolation kit in order to evaluate the changes of cytochrome c in the subcellular location, extracts of cytosolic, and mitochondrion. After the corresponding proteins were purified, their concentrations were quantified by a BCA protein assay kit. The fluorescent bands on the membranes stained with fluorescent antibodies were quantified by grave value analysis with respect to a control protein.
Statistical Analysis: The data were all presented as means ± standard deviation. The statistical differences between experimental groups were analyzed by Graphpad Prism 6 using the paired Dunnett's t-test or one-way ANOVA with a 95% confidence interval. A comparison under *, # P < 0.05 is considered statistically different between two groups.
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